1. Conditional Approval: Japan Lowers the Bar for Regenerative Medicine Products
2. Ministry of Health Labor and Welfare. Approval scheme in the emergency approval system [in Japanese]. Accessed June 2022.https://www.mhlw.go.jp/content/11120000/000940766.pdf
3. Ministry of Health Labor and Welfare. Review Report (2) [in Japanese]. Accessed November 22 2022.https://www.mhlw.go.jp/content/11121000/000966602.pdf
4. Efficacy and safety of ensitrelvir in patients with mild‐to‐moderate COVID‐19: A protocol for a multicenter, randomized, double‐blind, placebo‐controlled, phase 3 study (the SCORPIO‐SR trial);Yotsuyanagi H;medRxiv,2022
5. Japan's COVID‐19 treatment strategy: An examination of approved oral medications